Patents by Inventor Manuel Brehs

Manuel Brehs has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220226486
    Abstract: The present invention relates to a synthetic compound comprising at least one effector moiety and at least one binder moiety, wherein the effector moiety is associated to the binder moiety, and wherein further the effector moiety comprises a N-formyl methionine peptide which comprises an isoleucine residue.
    Type: Application
    Filed: March 23, 2022
    Publication date: July 21, 2022
    Inventors: Christian BECKER, Manuel BREHS, Karine THEWES, Ute STEINBUSCH, Andre JG PÖTGENS, Janett SCHWARZ
  • Patent number: 11318208
    Abstract: The present invention relates to a synthetic compound comprising at least one effector moiety and at least one binder moiety, wherein the effector moiety is associated to the binder moiety, and wherein further the effector moiety comprises a N-formyl methionine peptide which comprises an isoleucine residue (FIG. 1).
    Type: Grant
    Filed: May 24, 2017
    Date of Patent: May 3, 2022
    Assignee: SYNTAB THERAPEUTICS GMBH
    Inventors: Christian Becker, Manuel Brehs, Karine Thewes, Ute Steinbusch, Andre J G Pötgens, Janett Schwarz
  • Publication number: 20190201539
    Abstract: The present invention relates to a synthetic compound comprising at least one effector moiety and at least one binder moiety, wherein the effector moiety is associated to the binder moiety, and wherein further the effector moiety comprises a N-formyl methionine peptide which comprises an isoleucine residue (FIG. 1).
    Type: Application
    Filed: May 24, 2017
    Publication date: July 4, 2019
    Inventors: Christian Becker, Manuel Brehs, Karine Farbiarz, Ute Steinbusch, Andre JG Pötgens, Janett Schwarz